Transcatheter Embolization and Occlusion Devices Market Size, Share, Growth, and Industry Analysis, By Type (Embolization Coils, Coiling-assist Devices, Flow-diverting Devices, PV Embolization Coil, PV Plugs, Embolization Particles, Liquid Embolics, Accessories), By Application (Civil Household, Commercial (Cold Storage/Building etc), Environmental Monitoring, Chemical, Automobile), and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET OVERVIEW

The global transcatheter embolization and occlusion devices market size was USD 4.09 billion in 2025 and is projected to touch USD 6.83 billion by 2034, exhibiting a CAGR of 5.8% during the forecast period.

Not only are the Occlusion Devices Market and Transcatheter Embolization Devices growing, but also are doing so at a very fast pace that must not be disregarded. The rising acceptance of non-invasive operations and the global growing number of those with cardiovascular and vascular conditions could explain their rising popularity. Using these gadgets, blood arteries are purposely closed or obstructed to control several problems including aneurysms, arteriovenous malformations, malignancies, and pre-surgical vascular problems. The advent of microcoils, vascular plugs, and liquid embolic agents has not only increased their use but also increased their precision thanks to technological developments. of the operating rooms' methods.

Regarding geographic regions, North America is the top market player mostly because of its cutting-edge medical technology, robust research and development, and the prevalence of vascular conditions. Europe is slowly but consistently expanding thanks to its ageing population, backing from the medical insurance firms, and rising openness of non-invasive techniques. Conversely, the Asia-Pacific area is becoming the fastest expanding market in the world due to its rising healthcare spending, superior hospital amenities, and more patients undergoing advanced interventional treatment instruction. Though market obstacles include pricey equipment, drawn out approval procedures, and few competent interventional radiologists, For those willing to be creative in goods, enter developing countries, and meet the needs of market segments, the market presents excellent possibilities. the rising need for non-invasive surgical treatments performed outside of a hospital setting.

COVID-19 IMPACT

Transcatheter Embolization and Occlusion Devices Industry Had a Negative Effect Due to Delays in Elective Procedures during the COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The non-urgent interventions that were not immediately required were postponed during the COVID-19 pandemic; thus there was a temporary decline in the utilization of the devices. Particularly elective embolization procedures, tumor-related interventions, and non-critical occlusion treatments were greatly affected. Disruptions in global supply chains impacted the manufacturing as well as the distribution of medical devices including embolization devices. The shortage of raw materials, packaging, and components resulted in delayed deliveries and limited market growth during the pandemic, hence the difficulties in supplying the devices to the hospitals and other healthcare institutions.

The hospitals and the healthcare providers during the pandemic opted for the minimally invasive procedures because of the benefits such as shorter hospital stay for the patient and the lowering of the risk of COVID-19 exposure. This decision to prioritize the minimally invasive procedures also lead to the transcatheter embolization and occlusion devices being adopted faster since they are associated with shorter recovery times than open surgeries.

LATEST TRENDS

Ascendance of Liquid Embolic Agents (LEAs) to Drive Market Growth

Ascendance of Liquid Embolic Agents (LEAs) are vital benefits of transcatheter embolization and occlusion devices market share. Liquid embolic agents (LEAs) are becoming more visible in the market, and they are predicted to be the top-selling category during the years. Coming beyond the conventional coils, LEAs like those employing Ethylene-Vinyl Alcohol (EVOH) or cyanoacrylates are noted for their great reach. and completely obstruct complicated or extensively distributed vascular beds, as in the cases of hypervascular malignancies (such as liver cancer) and arteriovenous malformations (AVMs). Companies are investing massive sums of money in research and development of these compounds to improve their radiopacity, viscosity, and controlled polymerization time so that they might The likelihood of non-target embolization and catheter trapping is really low.

•   
•   
  

  Request a Free sample to learn more about this report

    

TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Embolization Coils, Coiling-assist Devices, Flow-diverting Devices, PV Embolization Coil, PV Plugs, Embolization Particles, Liquid Embolics, Accessories.

• Embolization Coils: Embolization coils are versatile and tiny devices that can completely block blood flow in specific vessels for example in the case of treating aneurysms and arteriovenous malformations which is their most common application. Their construction helps to start the process of clot formation and to seal the vessel with great accuracy permanently.

• Coiling-Assist Devices: Coiling-assist gadgets are useful in the procedure of embolization of the coils not only in complex or large neck aneurysms but also in their stabilization. Besides, they make it easier to place the coils at the right spot and at the same time, minimize the chances of migration of coils and non-target embolization.

• Flow-Diverting Devices: The primary function of flow-diverting devices is to steer blood away from arteries or aneurysms that are not functioning normally in order to encourage the natural healing of the vessel and eventually the closure. Usually, they are employed in the case of big or complex vascular malformations where standard coiling would not be effective.

• PV Embolization Coil: Portal vein (PV) embolization coils are specialized devices used to occlude specific veins prior to liver surgery or interventional procedures. They facilitate controlled blood flow diversion, aiding in preoperative planning and minimizing procedural complications.

• PV Plugs: Portal vein plugs are occlusion devices designed to block blood flow in targeted vessels, often used in combination with embolization coils. They provide rapid and secure vessel closure, particularly in larger or high-flow vascular channels.

• Embolization Particles: Embolization particles are tiny, biocompatible materials injected to occlude smaller blood vessels selectively. They are widely used for tumor treatment, reducing blood supply to lesions, and achieving targeted ischemia.

• Liquid Embolics: Liquid embolics are injectable fluids that solidify within blood vessels to create complete occlusion. They allow precise treatment of complex vascular malformations, aneurysms, and arteriovenous fistulas where coils or particles may be less effective.

• Accessories: Accessories include catheters, guidewires, and delivery systems that facilitate safe and accurate deployment of embolization and occlusion devices. They enhance procedural efficiency, reduce complications, and support device compatibility across varied clinical scenarios.

By Application

Based on application, the global market can be categorized into Cold Storage/Building, Environmental Monitoring, Chemical, Automobile.

• Cold Storage/Buildings: Distribution boards in cold storage facilities and specialized buildings manage power for refrigeration, HVAC, and lighting systems. They ensure safe and uninterrupted electricity supply, critical for maintaining temperature-sensitive goods and operational efficiency.

• Environmental Monitoring: In environmental monitoring facilities, distribution boards provide reliable power for sensors, data loggers, and analytical equipment. They help maintain consistent operation of systems that track air quality, water parameters, and other environmental metrics.

• Chemical: Distribution boards in chemical plants control and distribute electricity to reactors, pumps, mixers, and safety systems. They are designed to ensure operational safety, handle high loads, and protect against hazards in complex chemical processing environments.

• Automobile: In the automotive industry, distribution boards manage electricity for manufacturing lines, robotic systems, and testing equipment. They ensure efficient power distribution, safeguard machinery, and support continuous production in automotive plants.

MARKET DYNAMICS

Driving Factors

Rising Prevalence of Cardiovascular Diseases to Boost the Market

A factor in the transcatheter embolization and occlusion devices market growth is rising prevalence of cardiovascular diseases. The heightened global occurrence of cardiovascular diseases, aneurysms, arteriovenous malformations, and tumor-related vascular complications is the major reason for the market growth. The increase in the number of elderly people along with the rise in lifestyle-related risk factors lead to the necessity of the application of interventions that reduce morbidity and mortality. Transcatheter embolization and occlusion devices are effective solutions for such cases and thus are considered essential in today's vascular therapy. The developed and developing countries together with the high prevalence of vascular diseases ensure that there will always be demand for the devices in hospitals and specialized clinics.

Technological Advancements to Expand the Market

Microcoils, vascular plugs, flow-diverting devices, and liquid embolics are some of the innovations that have contributed to the significant improvement of procedural accuracy, safety, and clinical efficacy. The precision of placing the implant is improved by the advanced imaging-guided delivery systems, while the specialized materials used reduce the complications like migration or recanalization that may occur. The continuous R&D investment by the market players leads to the introduction of next-generation devices, expansion of clinical applications, and establishment of trust among interventional radiologists. The aging global population is prone to getting vascular abnormalities, aneurysms, and tumors, thus making the need for embolization therapies go up directly. The older patients are the major beneficiaries of the minimally invasive procedures as they experience lower physiological stress compared to open surgeries.

Restraining Factor

Procedural Risks and High Cost to Potentially Impede Market Growth

Though not very invasive, embolization therapies still carry certain hazards including non-target embolization, device migration, and vessel perforation. In some places or with less qualified physicians, safety issues about the procedure could stop it from being used. Reducing these risks calls for rigorous training and practice, but the learning curve might slow down the spread of the method. Expensive are transcatheter embolization and occlusion tools, notably modern microcoils, flow-diverters, and liquid embolics. High operational costs could be found in price-sensitive markets. particularly in developing countries, as a hurdle to access. The process of market penetration may be sluggish in hospitals with limited funds or by patients lacking enough insurance, hence delaying delivery of the treatment.

Product Innovation and Next-Generation Devices To Create Opportunity for the Product in the Market

Opportunity

Uninterrupted R&D brings about biodegradable coils, advanced liquid embolics, and highly precise flow-diverting devices. All these innovations work together to make the whole process safer, opening up new clinical applications and cutting down on complications, thus giving manufacturers a competitive advantage. In the Asia-Pacific, Latin America, and the Middle East, rapid urbanization, better healthcare facilities, and more people informed about the benefits of minimally invasive therapies are huge factors of the market growth.

Besides that, in these areas, increased healthcare spending and government initiatives for advanced interventional procedures are supporting the market penetration. The global trend of moving toward outpatient care and minimally invasive interventions coincides with the use of embolization and occlusion devices.

Intense Competition Could Be a Potential Challenge for Consumers

Challenge

Embolization devices may have to face surgical interventions, pharmaceutical treatments, and other interventional techniques as rivals mainly in terms of their costs or physicians' familiarity with the procedures. The existence of many options can reduce the share of the market and slow down the acceptance process in particular sectors. The technical difficulty of these operations requires the presence of specialized surgeons and technicians.

It is still a very hard task to train and place professionals who are capable of performing these procedures in all geographies, particularly in developing markets. High prices of the device, together with cash outlay for the procedure and little or no insurance coverage, can limit access in poor regions. Cost-effectiveness continues to be a major issue, especially in cases where the public healthcare budget is inadequate.

•   
•   
  Request a Free sample to learn more about this report

    

TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET REGIONAL INSIGHTS

• North America

North America is the fastest-growing region in this market. The United States transcatheter embolization and occlusion devices market has been growing exponentially for multiple reasons. With the well-established Active research and development in the field, a great prevalence of cardiovascular and vascular disorders, and a healthcare infrastructure. Thanks to the rising desire for minimally invasive techniques, great levels of patient knowledge, and great insurance coverage for interventional treatments, the U.S. controls the biggest part of the market. Another element boosting the acceptance of these gadgets is the spread of modern imaging and catheterization laboratories at hospitals and specialty clinics.

• Europe

The European market is constantly growing, and among the factors contributing to its growth are the aging population, high quality of healthcare, and the increasing use of minimally invasive procedures for vascular interventions. Germany, France, the United Kingdom, and Italy are the leading countries in terms of investments in interventional radiology infrastructure and advanced imaging technologies, which inevitably leads to high demand for embolization and occlusion devices. Good reimbursement policies and general knowledge about the importance of vascular health are the main reasons for the fast adoption of the products. The European market is also supported by regulatory challenges that force R&D teams to be more creative, thus leading to the production of devices that are more efficient and safer.

• Asia

Asia-Pacific is becoming the fastest-growing market globally, and this is mainly due to the rapid urbanization, the increase in healthcare expenditure, and the development of interventional radiology infrastructure mainly in China, India, Japan, and South Korea. Along with the increasing cardio-vascular and vascular disorders, the demand for embolization and occlusion devices is pushed up by the rising awareness of minimally invasive procedures. All these factors combined - particularly the government initiatives to improve healthcare access and private sector investments in hospitals and specialty clinics - are accelerating the adoption of such devices in this region. Besides, the trend of outpatient surgery and the presence of skilled interventional radiologists in urban areas are also contributing to market growth.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key industry players are shaping the Transcatheter Embolization and Occlusion Devices Market through continuous innovation and strategic expansion. These companies are adopting advanced manufacturing techniques and cutting-edge technologies to improve device safety, precision, and clinical effectiveness. They are diversifying their product portfolios to include microcoils, vascular plugs, flow-diverting devices, liquid embolics, and other specialized solutions, catering to the wide-ranging needs of patients with vascular disorders. Additionally, these organizations are leveraging digital platforms and advanced imaging guidance systems to enhance clinical adoption, streamline supply chains, and improve procedural efficiency, ensuring greater accessibility for hospitals and specialty clinics worldwide. By investing in research and development, optimizing manufacturing and delivery processes, and targeting emerging markets with high unmet medical needs.

List Of Top Transcatheter Embolization And Occlusion Devices Companies

• Abbott (U.S.)
• AtriCure (U.S.)
• Boston Scientific Corporation (U.S.)
• CeloNova (U.S.)
• Medtronic (Ireland)
• Cook Medical (U.S.)
• Cordis (U.S.)

KEY INDUSTRY DEVELOPMENT

August 2025: Instylla received U.S. FDA Premarket Approval (PMA) for its flagship product, the Embrace™ Hydrogel Embolic System (HES). This is a monumental development as it is the first and only liquid embolic agent approved specifically for the embolization of hypervascular tumors in peripheral arteries based on a prospective, randomized, controlled clinical trial.

REPORT COVERAGE

The study offers a detailed SWOT analysis and provides valuable insights into future developments within the market. It explores various factors driving market growth, examining a broad range of market segments and potential applications that may shape its trajectory in the coming years. The analysis considers both current trends and historical milestones to provide a comprehensive understanding of the market dynamics, highlighting potential growth areas.

The transcatheter embolization and occlusion devices market is poised for significant growth, driven by evolving consumer preferences, rising demand across various applications, and ongoing innovation in product offerings. Although challenges such as limited raw material availability and higher costs may arise, the market's expansion is supported by increasing interest in specialized solutions and quality improvements. Key industry players are advancing through technological advancements and strategic expansions, enhancing both supply and market reach. As market dynamics shift and demand for diverse options increases, the transcatheter embolization and occlusion devices market is expected to thrive, with continuous innovation and broader adoption fueling its future trajectory.